RARE DISEASES A–Z · LETTER G

Guillain-Barré Syndrome

Guillain-Barré syndrome (GBS) is a rare but well-known neurological emergency: the immune system, usually triggered by a recent infection, attacks the peripheral nerves. Weakness climbs from the legs upward over days to a few weeks — and because it can reach the breathing muscles, GBS is always managed in hospital.

By Dr. Mohamed Ibrahim, MD, PhD — Assistant Professor of Medicine, Transplant Nephrology, University of Maryland School of Medicine · Last reviewed: November 2026

Rare Diseases A–Z is part of the MedicalVideos.com education program. It is produced independently of sponsors, and any future sponsorship will be labelled on the hub.

In short: Guillain-Barré syndrome is a post-infection immune attack on peripheral nerves causing ascending weakness over days to weeks; breathing can fail. Plasma exchange or immunoglobulin shortens it. Most people recover well over months.

The guide

The basics

The immune attack strips the myelin insulation from peripheral nerves (the commonest form in Europe and North America) or damages the nerve fibres themselves (commoner in Asia and Latin America). Weakness typically starts in both legs, is symmetrical, and climbs — to the trunk, arms, and sometimes the face and swallowing muscles. Reflexes disappear. Tingling and pain — often severe back or limb pain — accompany the weakness. The autonomic nerves can be involved, causing dangerous swings in heart rate and blood pressure. Progression stops within four weeks by definition, but at its worst, around a fifth to a third of patients need a ventilator because the breathing muscles fail. The illness is monophasic: after a plateau, recovery unfolds over months.

How it works

Diagnosis is clinical first: symmetrical ascending weakness with absent reflexes after an infection is GBS until proved otherwise. Spinal fluid classically shows high protein with a normal white cell count — though it can be normal in the first week. Nerve conduction studies confirm the nerve pattern and subtype, and may also be normal very early. MRI of the spine and blood tests help exclude mimics — spinal cord compression is the emergency alternative that must not be missed, along with conditions such as transverse myelitis, botulism, and acute porphyria. Stool or blood tests sometimes identify the triggering infection (Campylobacter, influenza, EBV, CMV, and others) but treatment does not wait for them.

Day to day

Two treatments shorten the illness when given early: plasma exchange, which filters the attacking antibodies from the blood, and intravenous immunoglobulin (IVIg), a concentrated preparation of pooled antibodies that calms the immune attack. They are alternatives — combining them adds nothing — and benefit is greatest when started within the first two weeks, while weakness is progressing. Steroids, surprisingly, do not help. The other half of treatment is meticulous supportive care: monitoring breathing capacity at the bedside, intensive care when needed, preventing clots and pressure damage, managing autonomic swings, treating the often severe nerve pain, and starting rehabilitation early. Most people improve substantially; recovery is measured in months, and fatigue can outlast the weakness.

When to get help

After discharge, recovery is actively managed: physiotherapy and occupational therapy rebuild strength and function, and fatigue — often the most stubborn symptom — is paced rather than pushed through. Neuropathic pain usually settles but may need treatment for a time. Most improvement happens in the first year, though gains continue into the second. Contact the team promptly for new worsening after initial recovery (which can suggest a treatment-related fluctuation or a different diagnosis), swallowing problems, or mood difficulties — depression after GBS is common and treatable. Vaccinations afterwards are discussed individually; the flu vaccine is usually recommended with timing agreed with your team.

See a doctor promptly if: Weakness that is progressing day by day, difficulty breathing, choking on saliva, or inability to swallow needs emergency care — do not wait at home.

Common questions

Who were Guillain and Barré?

It is named after Georges Guillain and Jean-Alexandre Barré, French neurologists who described the spinal fluid pattern of the disease in soldiers in 1916. Their colleague André Strohl was also on the original paper, which is why some countries call it Guillain-Barré-Strohl syndrome.

Will I recover fully?

Most people recover substantially: the majority walk independently by six months, and many recover fully, though fatigue and some residual numbness or weakness are common and recovery can continue for two years or more. A minority are left with significant disability, and the disease can very rarely be fatal, usually through breathing or autonomic complications in the acute phase.

Do steroids help in Guillain-Barré syndrome?

No — interestingly, steroids alone have been shown not to help in GBS, unlike in many other immune conditions. The treatments with proven benefit are plasma exchange and intravenous immunoglobulin; giving both together adds nothing over either alone.

Can GBS come back?

Very rarely. GBS is usually a one-off illness. Weakness that progresses beyond eight weeks, or that repeatedly worsens after improving, suggests a different diagnosis — chronic inflammatory demyelinating polyneuropathy (CIDP) — which needs different, long-term treatment.

More in Letter G

Related

This guide is general information, not medical advice. Rare diseases are individual — diagnosis and treatment depend on your own results, other conditions, and treatment history, and are set by your treating team. Never start, stop, or change a medicine because of something you read here. If you have severe breathlessness, uncontrolled bleeding, confusion, sudden weakness, or thoughts of harming yourself, seek urgent care. GBS is managed in hospital; breathing and swallowing decisions belong to your treating team.